Literature DB >> 11491502

A comparative study of outcome in myositis and other musculoskeletal disorders assessed using the Nottingham health profile.

Y L Chung1, H L Mitchell, D A Houssien, H Al-Mahrouki, A J Carr, D L Scott.   

Abstract

OBJECTIVE: This study evaluated the comparative impact of myositis and other musculoskeletal disorders on general health using the Nottingham health profile (NHP) as a generic measure of health status.
METHODS: A prospective observational study of 113 females with myositis, 142 females with rheumatoid arthritis, 45 females with spinal osteoporosis and 96 females with knee osteoarthritis.
RESULTS: All mean NHP section scores were higher in myositis and other musculoskeletal disorders compared to population mean values. Section scores for energy and social isolation were high in myositis compared to all other disorders. Scores for physical disability in myositis were similar to RA. Pain scores were higher in RA and OA compared to myositis. Backwards linear regression models explained 26-42% of the variation in energy and social isolation scores. Emotion and physical section scores were the major determinants and the pattern was similar in all disorders. Disease duration and age had little effect.
CONCLUSIONS: Myositis is not simply a disease with physical problems but has wide ranging effects on social and emotional well being. Until disease-specific instruments are available, a generic measure like the NHP can be used to assess problems other than muscle pain and loss of strength.

Entities:  

Mesh:

Year:  2001        PMID: 11491502

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  13 in total

Review 1.  Health related quality of life outcome instruments.

Authors:  Gunnar Németh
Journal:  Eur Spine J       Date:  2005-12-01       Impact factor: 3.134

Review 2.  Patient-Reported Outcomes in Adult Idiopathic Inflammatory Myopathies.

Authors:  Dana DiRenzo; Clifton O Bingham; Christopher A Mecoli
Journal:  Curr Rheumatol Rep       Date:  2019-11-19       Impact factor: 4.592

Review 3.  Exercise: an important component of treatment in the idiopathic inflammatory myopathies.

Authors:  Helene Alexanderson
Journal:  Curr Rheumatol Rep       Date:  2005-04       Impact factor: 4.592

4.  Quality of life correlates with muscle strength in patients with dermato- or polymyositis.

Authors:  Karina B Poulsen; Helene Alexanderson; Christine Dalgård; Søren Jacobsen; Louise Weile; Louise P Diederichsen
Journal:  Clin Rheumatol       Date:  2017-06-06       Impact factor: 2.980

5.  Long-term outcome in polymyositis and dermatomyositis.

Authors:  I M Bronner; M F G van der Meulen; M de Visser; S Kalmijn; W J van Venrooij; A E Voskuyl; H J Dinant; W H J P Linssen; J H J Wokke; J E Hoogendijk
Journal:  Ann Rheum Dis       Date:  2006-04-10       Impact factor: 19.103

6.  Predictors of Reduced Health-Related Quality of Life in Adult Patients With Idiopathic Inflammatory Myopathies.

Authors:  Michal Feldon; Payam Noroozi Farhadi; Hermine I Brunner; Lukasz Itert; Bob Goldberg; Abdullah Faiq; Jesse Wilkerson; Kathryn M Rose; Lisa G Rider; Frederick W Miller; Edward H Giannini
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-09-21       Impact factor: 4.794

Review 7.  Patient-reported outcomes and adult patients' disease experience in the idiopathic inflammatory myopathies. report from the OMERACT 11 Myositis Special Interest Group.

Authors:  Helene Alexanderson; Maria Del Grande; Clifton O Bingham; Ana-Maria Orbai; Catherine Sarver; Katherine Clegg-Smith; Ingrid E Lundberg; Yeong Wook Song; Lisa Christopher-Stine
Journal:  J Rheumatol       Date:  2014-01-15       Impact factor: 4.666

8.  En bloc resection and intercalary prosthesis implantation for the treatment of humeral diaphyseal bone metastases.

Authors:  Feifei Pu; Zhicai Zhang; Baichuan Wang; Jianxiang Liu; Zengwu Shao
Journal:  Int Orthop       Date:  2020-10-06       Impact factor: 3.075

9.  Health-related quality of life and well-being in adults with idiopathic inflammatory myopathy.

Authors:  Imma Armadans-Tremolosa; Albert Selva-O'Callaghan; Bienvenido Visauta-Vinacua; Georgina Guilera; Iago Pinal-Fernández; Miquel Vilardell-Tarrés
Journal:  Clin Rheumatol       Date:  2014-06-04       Impact factor: 2.980

10.  213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015.

Authors:  Olivier Benveniste; Lisa G Rider
Journal:  Neuromuscul Disord       Date:  2016-05-27       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.